HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Second and third-look endoscopy for the prevention of post-ESD bleeding.

Abstract
The efficacy of 2nd-look esophagogastroduodenoscopy (EGD) with endoscopic hemostatic therapy (EHT) for the prevention of postendoscopic submucosal dissection (ESD) clinical bleeding remains controversial. The aim of this study was to estimate post-ESD bleeding rate using 2nd and 3rd-look strategy, and to determine risk factors for clinical bleeding, and for EHT at 2nd and 3rd-look EGDs.Three hundred forty-four consecutive patients with early gastric cancer or adenoma underwent ESD from January 2006 through March 2012. Second and 3rd-look EGDs were performed on day 1 (D1) and day 7 (D7), respectively, with EHT as needed.Post-ESD clinical bleeding rate was 2.6% (95% confidence interval [CI] 1.2%-4.9%). For clinical bleeding, adjusted odds ratios (ORs) for age <65 years and antithrombotic drug uses were 4.40 (95% CI 1.07-19.93) and 7.34 (95% CI 1.80-32.48), respectively. For D1 EHT, adjusted ORs of tumor location in the lower part of the stomach and maximum tumor diameter ≥60 mm were 2.16 (95% CI 1.35-3.51) and 2.20 (95% CI 1.05-4.98), respectively. For D7 EHT, adjusted OR of D1 EHT was 4.65 (95% CI 1.56-20.0).Post-ESD clinical bleeding rate was relatively low using 2nd and 3rd-look strategy. Age <65 years and antithrombotic drug use are significant risk factors for clinical bleeding. Regarding EHT, tumor location in the lower part of the stomach and maximum diameter of resected specimen ≥60 mm are significant predictors for D1 EHT. D1 EHT in turn is a significant risk factor for D7 EHT. The efficacy of sequential strategy for preventing post-ESD bleeding is promising.
AuthorsShunsuke Tano, Noriyuki Horiki, Fumio Omata, Kyosuke Tanaka, Yasuhiko Hamada, Masaki Katsurahara, Katsuhito Ninomiya, Kenichiro Nishikawa, Keiichiro Nojiri, Reiko Yamada, Hiroyuki Inoue, Esteban C Gabazza, Naoyuki Katayama, Yoshiyuki Takei
JournalMedicine (Medicine (Baltimore)) Vol. 94 Issue 6 Pg. e491 (Feb 2015) ISSN: 1536-5964 [Electronic] United States
PMID25674738 (Publication Type: Journal Article)
Chemical References
  • Fibrinolytic Agents
Topics
  • Age Factors
  • Aged
  • Endoscopy, Digestive System
  • Endoscopy, Gastrointestinal
  • Female
  • Fibrinolytic Agents (adverse effects)
  • Hemostatic Techniques
  • Humans
  • Male
  • Postoperative Hemorrhage (etiology, prevention & control)
  • Risk Factors
  • Second-Look Surgery
  • Stomach Neoplasms (surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: